Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
About Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
The Quinze-Vingts National Ophthalmology Hospital is France's national ophthalmology hospital located in Paris, in the 12th arrondissement. The hospital gave its name to the Quinze-Vingts quarter.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
During the past decade, Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts conducted 38 clinical trials. In the 10-year time frame, 38 clinical trials started and 4 clinical trials were completed, i.e. on
average, 10.5% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 1 clinical trials were completed. i.e. 8.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Evaluating the Use of Oseltamivir for the Treatment of Influenza in Adults
2011-04-01
2017-11-18
Completed
716
Positive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate Cancer
2012-01-01
2017-07-01
Terminated
225
Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer
2013-10-31
2023-12-29
Active, not recruiting
1,401
Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)
2014-12-17
2026-09-19
Active, not recruiting
1,068
A Study of Galeterone Compared to Enzalutamide In Men Expressing Androgen Receptor Splice Variant-7 mRNA (AR-V7) Metastatic CRPC
2015-06-01
2016-11-01
Terminated
953
Evaluate the Effect of ALLN-177 in Reducing Urinary Oxalate in Patients With Secondary Hyperoxaluria and Kidney Stones Over 28 Days
2015-09-01
2017-01-01
Completed
66
Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1 Esterase Inhibitor for the Prevention of Angioedema Attacks in Adolescents and Adults With Hereditary Angioedema
2015-11-01
2017-07-24
Completed
75
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts" #1 sponsor was "Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts" with 9 trials, followed by "Hoffmann-La Roche" with 5 trials
sponsored, "Laboratoires Thea" with 4 trials sponsored, "Centre Hospitalier Intercommunal Creteil" with 3 trials sponsored and "GenSight Biologics"
with 3 trials sponsored. Other sponsors include 25 different institutions and
companies that sponsored additional 25 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts"
#1 collaborator was "Foundation Fighting Blindness" with 3 trials as a collaborator, "Bayer" with 2 trials as a collaborator, "Keyrus Biopharma" with 2 trials as a collaborator, "ADDMEDICA SASA" with 1 trials as a collaborator and "APHP" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were
collaborators in the rest 15 trials.
Clinical Trials Conditions at Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
According to Clinical.Site data, the most researched conditions in "Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts" are
"Retinitis Pigmentosa" (9 trials), "Geographic Atrophy" (6 trials), "Eye Diseases" (4 trials), "Glaucoma" (4 trials) and "Retinal Degeneration" (4 trials). Many other conditions were trialed in "Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts" in a lesser frequency.
Clinical Trials Intervention Types at Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
Most popular intervention types in "Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts" are "Drug" (18 trials), "Device" (16 trials), "Other" (12 trials), "Biological" (3 trials) and "Genetic" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Aflibercept" (2 trials), "Blephasteam" (2 trials), "GS010" (2 trials) and "Intelligent Retinal Implant System" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
The vast majority of trials in "Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts" are
54 trials for "All" genders.
Clinical Trials Status at Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
Currently, there are NaN active trials in "Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts".
undefined are not yet recruiting,
11 are recruiting,
12 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 22 completed trials in Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts,
undefined suspended trials,
and 5 terminated clinical trials to date.
Out of the total trials that were conducted in Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, 2 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 13 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 5 trials, and there were
also 13 trials that are defined as “Not Applicable".